Default: Expert Review of Vaccines

ISSN: 1476-0584

Journal Home

Journal Guideline

Expert Review of Vaccines Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Vaccines is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 105. It has a price of 4000 €. It has an SJR impact factor of 1,412 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,412.

Expert Review of Vaccines focuses its scope in these topics and keywords: vaccines, vaccine, diseases, neglected, pcv, hiv, iii, immunoinformatics, impact, designplantbased, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Expert Review of Vaccines

1,412

SJR Impact factor

105

H Index

110

Total Docs (Last Year)

409

Total Docs (3 years)

7915

Total Refs

2013

Total Cites (3 years)

364

Citable Docs (3 years)

5.1

Cites/Doc (2 years)

71.95

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


vaccines, vaccine, diseases, neglected, pcv, hiv, iii, immunoinformatics, impact, designplantbased, human, latin, malaria, medicinecryptic, nanoparticlesposthoc, neutralizing, nonvaccine, papillomavirus, perspectivesaiming, future, forgotten, antibodies, antibody, atime, based, broadly, candidatesvaccine, conjugate, considerations, current, design, development, emerging, epitope,



Best articles by citations

Serologic correlates of protection for evaluating the response to meningococcal vaccines

View more

Use of attenuated paramyxoviruses for cancer therapy

View more

Current status and future prospects for a vaccine against schistosomiasis

View more

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine

View more

Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases

View more

Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups

View more

Plant production systems for vaccines

View more

Virus-like antigen display for cancer vaccine development, what is the potential?

View more

Overview of mimotopes and related strategies in tumor vaccine development

View more

In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains

View more

Pneumococcal conjugate vaccines: emerging clinical information and its implications

View more

Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report

View more
SHOW MORE ARTICLES

Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine

View more

Pertussis: should we improve intensive care management or vaccination strategies?

View more

The immunization imperative

View more

Progress in filovirus vaccine development: evaluating the potential for clinical use

View more

Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial

View more

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

View more

Norwalk virus-like particles as vaccines

View more

Reimmunization after hematopoietic stem cell transplantation

View more

Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer

View more

What do the next 100 years hold for pneumococcal vaccination?

View more

A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed

View more

Design of tuberculosis vaccine trials under financial constraints

View more

FAQS